UPMC Honors Stanley M. Marks, MD, With Endowed Chair in Hematology/Oncology Leadership


Get Permission

Stanley M. Marks, MD

Stanley M. Marks, MD

The University of Pittsburgh Medical Center (UPMC) announced that Stanley M. Marks, MD, oncologist and advocate for cancer patients throughout the western Pennsylvania region, is being honored by the UPMC and his medical partners at Oncology Hematology Association (OHA) through the establishment of the Stanley M. Marks–OHA Endowed Chair in Hematology/Oncology Leadership.

The permanent endowment will support the recruitment and retention of outstanding leaders in the University of Pittsburgh Division of Hematology/Oncology. It also will help to train professionals devoted to research and improved treatments for patients.

Dr. Marks has directed and overseen the continued growth and success of the UPMC Cancer Center, a partner with the University of Pittsburgh Cancer Institute.

“None of this would have been possible without the support of my colleagues and UPMC,” said Dr. Marks. “This endowment will enable us to recruit a medical and scientific star, ultimately leading to better care for our patients.” 

Lasting Legacy

Barry Lembersky, MD, Clinical Professor of Medicine at the University of Pittsburgh, said “Through his decades-long leadership of OHA and the UPMC Cancer Center, Stan has made a significant impact on cancer care and research in our region and beyond. All of the physicians in OHA wish to honor his outstanding contributions and provide a legacy to benefit patients for generations to come.” 

Dr. Marks serves as Chairman of UPMC Cancer Center, Chief of the Division of Hematology and Oncology at UPMC Shadyside, and Clinical Professor of Medicine at the University of Pittsburgh School of Medicine. ■


Advertisement

Advertisement



Advertisement